JNCE
Jounce Therapeutics Inc
Price:  
1.88 
USD
Volume:  
11,600,600.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

JNCE Stock Forecast & Price Target

JNCE Stock Price Forecast

The average stock forecast for Jounce Therapeutics Inc (JNCE) in the next 12 months is 1.65 USD. This price target corresponds to an upside of -12.29%. The range of stock forecasts for JNCE is 1.01 - 2.10 USD. Based on the ratings of 13 analysts, the consensus recommendation for JNCE is BUY.
Target Low Average Median High
Price (USD) 1.01 1.65 1.89 2.10
Upside -46.28% -12.29% 0.37% 11.70%

Recommendation Trends

The latest consensus rating for JNCE is "BUY". This is the average recommendation of 13 analysts: 0 strong sell, 0 sell, 3 hold, 7 buy, 3 strong buy. In the previous period, 13 analysts also majorly recommmended "BUY" for JNCE.

JNCE Financial Stock Forecast

Revenue This Year
-M
-100.00%
from 82.00M
Revenue Next Year
-M
from -M
EPS This Year
-1.35
39.38%
from -0.97
EPS Next Year
-1.04
-22.85%
from -1.35